High-dose insulin infusion in patients with COVID-19.

Del Carpio, Brandon; Trang, Joseph; Vallejo, Megan; Nimeh, Michael; Lee, Jinjoo; Rafferty, Kelly; Messler, Jordan

Del Carpio, Brandon; Trang, Joseph; Vallejo, Megan; Nimeh, Michael; Lee, Jinjoo; Rafferty, Kelly; Messler, Jordan.

Del Carpio B; Pharmacy, AdventHealth Orlando, Orlando, Florida, USA brandon.delcarpio@adventhealth.com.
Trang J; Pharmacy, AdventHealth East Orlando, Orlando, Florida, USA.
Vallejo M; Pharmacy, AdventHealth East Orlando, Orlando, Florida, USA.
Nimeh M; Pharmacy, AdventHealth East Orlando, Orlando, Florida, USA.
Lee J; Pharmacy, AdventHealth East Orlando, Orlando, Florida, USA.
Rafferty K; Pharmacy, AdventHealth Central Florida, Orlando, Florida, USA.
Messler J; Chief Medical Officer, Glytec, Waltham, Massachusetts, USA.

BMJ Open Diabetes Res Care ; 9(2)2021 11.

Article in English | MEDLINE | ID: covidwho-1515288

Subject(s)

COVID-19; Humans; Insulin; Insulin Infusion Systems; SARS-CoV-2

Keywords

COVID-19; diabetes mellitus; hyperglycemia; insulin infusion systems; type 2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: Bmjdrc-2021-002415

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google